These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32484873)

  • 1. Comparative Safety of Smoking Cessation Pharmacotherapies During a Government-Sponsored Reimbursement Program.
    Carney G; Maclure M; Malfair S; Bassett K; Wright JM; Dormuth CR
    Nicotine Tob Res; 2021 Jan; 23(2):302-309. PubMed ID: 32484873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non-depressed adults: a retrospective cohort study.
    Carney G; Bassett K; Maclure M; Taylor S; Dormuth CR
    Addiction; 2020 Aug; 115(8):1534-1546. PubMed ID: 32077187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia.
    Havard A; Choi SKY; Pearson SA; Chow CK; Tran DT; Filion KB
    JAMA Netw Open; 2021 Nov; 4(11):e2136372. PubMed ID: 34842922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.
    Mills EJ; Thorlund K; Eapen S; Wu P; Prochaska JJ
    Circulation; 2014 Jan; 129(1):28-41. PubMed ID: 24323793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database.
    Kotz D; Simpson C; Viechtbauer W; van Schayck OC; West R; Sheikh A
    BMJ Open; 2014 Aug; 4(8):e005281. PubMed ID: 25168037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
    Hays JT; Ebbert JO
    Drugs; 2010 Dec; 70(18):2357-72. PubMed ID: 21142259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in utilization of smoking cessation agents before and after the passage of FDA boxed warning in the United States.
    Shah D; Shah A; Tan X; Sambamoorthi U
    Drug Alcohol Depend; 2017 Aug; 177():187-193. PubMed ID: 28605678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study.
    Johnson M; Anderson P; Lockhart I
    BMC Fam Pract; 2014 Mar; 15():47. PubMed ID: 24645823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease.
    Kotz D; Viechtbauer W; Simpson CR; van Schayck OCP; West R; Sheikh A
    Thorax; 2017 Oct; 72(10):905-911. PubMed ID: 28473506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.
    Kozak K; George TP
    Expert Opin Pharmacother; 2020 Apr; 21(5):581-590. PubMed ID: 32011186
    [No Abstract]   [Full Text] [Related]  

  • 15. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine replacement therapy for smoking cessation.
    Stead LF; Perera R; Bullen C; Mant D; Hartmann-Boyce J; Cahill K; Lancaster T
    Cochrane Database Syst Rev; 2012 Nov; 11():CD000146. PubMed ID: 23152200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study.
    Kotz D; Viechtbauer W; Simpson C; van Schayck OC; West R; Sheikh A
    Lancet Respir Med; 2015 Oct; 3(10):761-8. PubMed ID: 26355008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying sequential episodes of pharmacotherapy as a method for assessing treatment failure in comparative effectiveness research.
    Carney G; Maclure M; Bassett K; Taylor S; Dormuth CR
    Pharmacoepidemiol Drug Saf; 2020 Feb; 29(2):199-207. PubMed ID: 31793135
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.